Zero Candida Ltd (TSX-V:ZCT) on Wednesday commenced trading on the OTCQB Venture Market under the ticker symbol “ZCTFF.”
The FemTech company is developing a tampon-like device that leverages AI and therapeutic blue light at a precise wavelength and intensity to treat Candida fungus, with a 99.999% success rate.
"Today's announcement is another exciting milestone for Zero Candida's long-term growth,” CEO Eli Ben Haroosh said in a statement.
The CEO added that the listing comes at an important time for the company amid patent advancements and the rapid growth of the vulvovaginal candidiasis market.
“We look forward to expanding our market presence and strategic partnerships, broadening our investor base to support our mission, and unlock substantial value through AI-driven medical technology,” he said.
The company's shares will also continue to trade on the TSX Venture Exchange and Frankfurt Stock Exchange.